- Home
- STEP vs KRYS Comparison
STEP vs KRYS Comparison
Compare STEP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEP
- KRYS
- Stock Information
- Founded
- STEP 2007
- KRYS 2015
- Country
- STEP United States
- KRYS United States
- Employees
- STEP N/A
- KRYS N/A
- Industry
- STEP Finance/Investors Services
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STEP Finance
- KRYS Health Care
- Exchange
- STEP Nasdaq
- KRYS Nasdaq
- Market Cap
- STEP 4.7B
- KRYS 5.1B
- IPO Year
- STEP 2020
- KRYS 2017
- Fundamental
- Price
- STEP $65.00
- KRYS $170.74
- Analyst Decision
- STEP Hold
- KRYS Strong Buy
- Analyst Count
- STEP 8
- KRYS 8
- Target Price
- STEP $59.25
- KRYS $199.43
- AVG Volume (30 Days)
- STEP 577.3K
- KRYS 256.8K
- Earning Date
- STEP 11-07-2024
- KRYS 11-04-2024
- Dividend Yield
- STEP 0.69%
- KRYS N/A
- EPS Growth
- STEP N/A
- KRYS N/A
- EPS
- STEP 0.63
- KRYS 1.77
- Revenue
- STEP $800,276,000.00
- KRYS $241,519,000.00
- Revenue This Year
- STEP $25.75
- KRYS $485.65
- Revenue Next Year
- STEP $16.22
- KRYS $58.64
- P/E Ratio
- STEP $103.86
- KRYS $96.29
- Revenue Growth
- STEP 48.87
- KRYS 2722.80
- 52 Week Low
- STEP $25.06
- KRYS $97.30
- 52 Week High
- STEP $70.38
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- STEP 56.97
- KRYS 41.38
- Support Level
- STEP $63.72
- KRYS $182.26
- Resistance Level
- STEP $70.38
- KRYS $207.84
- Average True Range (ATR)
- STEP 2.60
- KRYS 8.77
- MACD
- STEP 0.13
- KRYS -0.21
- Stochastic Oscillator
- STEP 55.57
- KRYS 16.02
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.